COVID-19 has inspired renewed urgency in the need for weapons to combat antimicrobial resistant infections and new hope of government funding to meet the challenge.

The threat of antibiotic resistance is no longer looming — it’s already here. So-called “superbug” infections killed 1.27 million people worldwide in 2019, causing more deaths than HIV or malaria. And COVID-19 has only exacerbated the problem.

Despite this gloomy outlook, attendees of the World Antimicrobial Resistance Congress held last week in Washington, D.C., appeared optimistic that a new era marked by increased government attention could be afoot…

Read the full story in PharmaVoice here